genomic evolution of nsclc during the establishment of patient-derived xenograft models
Published 1 year ago • 38 plays • Length 5:28Download video MP4
Download video MP3
Similar videos
-
1:02
patient-derived xenograft models for preclinical oncology research
-
1:33
tracking non-small cell lung cancer evolution through therapy (rx) (tracerx)
-
1:07
the advantages of patient-derived using xenograft models for preclinical oncology research
-
2:32
genomic testing for lung cancer in the uk
-
0:52
dr. lopategui on the evolution of molecular testing in nsclc
-
1:47
the development of surgery for lung cancer with the evolution of neoadjuvant/adjuvant treatment
-
1:07
integration of radiology, pathology, & genomics for prediction of response to anti-pd-1 in nsclc
-
1:00
the genetic landscape of lung cancer
-
5:03
genetic testing for nsclc
-
4:41
history of kras testing in advanced nsclc
-
1:37
ngs for the detection of mutations in nsclc
-
2:55
limitations of genetic testing for actionable mutations in lung cancer
-
1:23
optimal positioning of liquid biopsies in the workup of patients with nsclc
-
1:05:35
genomic landscape of lung cancer
-
59:01
genomic landscape of lung adenocarcinoma
-
6:55
the prognostic value of ctdna in nsclc treated with neoadjuvant chemoimmunotherapy
-
3:28
the future of nsclc treatment
-
3:32
the role of ctdna in lung cancer screening
-
4:08
targeted therapies in lung cancer